Venture capital has been on a good run over the past few years across a range of sectors; even with recent slowdown relative to 2014-2015, venture-backed investments remain above historic averages. In fact, the first three quarters of 2016 alone are already higher than the annual rate of venture investing in all but two years since 2002.
{iframe}http://www.forbes.com/sites/brucebooth/2016/11/21/biotech-venture-capital-mythbusting-redux/#2cbfe91b7a53{/iframe}